Acadia Pharmaceuticals (ACAD) shares ended the last trading session 6.1% higher at $14.96. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Acadia Healthcare Co's ACHC short percent of float has risen 27.18% since its last report. The company recently reported that ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Commonwealth Equity Services LLC grew its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 190.0% during the 4th quarter, according to its most recent filing with the Securities ...

Prudential Financial Inc. bought a new stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) in the fourth quarter ...

March 27 (Reuters) - India's market regulator is investigating possible insider trading among senior officials of IndusInd Bank (INBK.NS), opens new tab amid significant accounting lapses by the ...

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United ...

The regulatory body has also ordered Hemant and Jaya Ghai to disgorge ₹6.1 crore, along with 12% simple interest from 31 March 2020, representing the profits they gained through insider trading ...

In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ ... particularly those trading under $20, may find attractive options within the index.

In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands against other best Nasdaq stocks under $20 to buy now. The Nasdaq has had a challenging start ...